Malignant Arrhythmogenic Role Associated with RBM20: A Comprehensive Interpretation Focused on a Personalized Approach

The RBM20 gene encodes the muscle-specific splicing factor RNA-binding motif 20, a regulator of heart-specific alternative splicing. Nearly 40 potentially deleterious variants in RBM20 have been reported in the last ten years, being found to be associated with highly arrhythmogenic events in familia...

Descripción completa

Detalles Bibliográficos
Autores: Jordà, Paloma, Toro, Rocío, Diez, Carles, Salazar-Mendiguchía, Joel, Fernández-Falgueras, Anna, Perez-Serra, Alexandra, Coll Vidal, Mònica, Puigmulé, Marta, Arbelo, Elena, García Álvarez, Ana, Sarquella Brugada, Geòrgia, Cesar, Sergi, Tirón de Llano, Coloma, Iglesias, Anna, Brugada Terradellas, Josep, Brugada, Ramon, Campuzano Larrea, Oscar
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10256/19157
Acceso en línea:http://hdl.handle.net/10256/19157
Access Level:acceso abierto
Palabra clave:Arrítmia
Arrhythmia
Cor -- Malalties
Heart -- Diseases
Genotip
Génotype
Cor -- Malalties -- Aspectes genètics
Heart -- Diseases -- Genetic aspects
Mort sobtada
Sudden death
Descripción
Sumario:The RBM20 gene encodes the muscle-specific splicing factor RNA-binding motif 20, a regulator of heart-specific alternative splicing. Nearly 40 potentially deleterious variants in RBM20 have been reported in the last ten years, being found to be associated with highly arrhythmogenic events in familial dilated cardiomyopathy. Frequently, malignant arrhythmias can be a primary manifestation of disease. The early recognition of arrhythmic genotypes is crucial in avoiding lethal episodes, as it may have an impact on the adoption of personalized preventive measures. Our study performs a comprehensive update of data concerning rare variants in RBM20 that are associated with malignant arrhythmogenic phenotypes with a focus on personalized medicine